These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24830987)

  • 1. Development and Successful Validation of Simple and Fast TLC Spot Tests for Determination of Kryptofix® 2.2.2 and Tetrabutylammonium in 18F-Labeled Radiopharmaceuticals.
    Kuntzsch M; Lamparter D; Brüggener N; Müller M; Kienzle GJ; Reischl G
    Pharmaceuticals (Basel); 2014 May; 7(5):621-33. PubMed ID: 24830987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fast and Simple Method for the Determination of TBA in
    Halvorsen NE; Kvernenes OH
    Pharmaceuticals (Basel); 2020 Feb; 13(2):. PubMed ID: 32054093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use.
    Scott PJ; Kilbourn MR
    Appl Radiat Isot; 2007 Dec; 65(12):1359-62. PubMed ID: 17582776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A spot test for determination of residual TBA levels in
    Tanzey SS; Mossine AV; Sowa AR; Torres J; Brooks AF; Sanford MS; Scott PJH
    Anal Methods; 2020 Nov; 12(41):5004-5009. PubMed ID: 33000785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Kryptofix 2.2.2 in [18F]fluorine-labelled radiopharmaceuticals by rapid-resolution liquid chromatography.
    Lao Y; Yang C; Zou W; Gan M; Chen P; Su W
    Nucl Med Commun; 2012 May; 33(5):498-502. PubMed ID: 22330082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography.
    Yap CS; Czernin J; Fishbein MC; Cameron RB; Schiepers C; Phelps ME; Weber WA
    Chest; 2006 Feb; 129(2):393-401. PubMed ID: 16478857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging.
    Debebe SA; Goryawala M; Adjouadi M; Mcgoron AJ; Güleç SA
    Mol Imaging Radionucl Ther; 2016 Feb; 25(1):32-8. PubMed ID: 27299286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A color spot test for the detection of Kryptofix 2.2.2 in [18F]FDG preparations.
    Mock BH; Winkle W; Vavrek MT
    Nucl Med Biol; 1997 Feb; 24(2):193-5. PubMed ID: 9089712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel methods for the quantification of toxic, residual phase transfer catalyst in fluorine-18 labeled radiotracers.
    Blevins DW; Rigney GH; Fang MY; Akula MR; Osborne DR
    Nucl Med Biol; 2019; 74-75():41-48. PubMed ID: 31473491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convenient and Efficient Method for Quality Control Analysis of 18F-Fluorocholine: For a Small Scale GMP-based Radiopharmaceuticals Laboratory Set-up.
    Hassan H; Abu Bakar S; Halim KN; Idris J; Nordin AJ
    Curr Radiopharm; 2016; 9(2):128-36. PubMed ID: 26013570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
    Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
    Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 18F-FLT PET and 18F-FDG PET in esophageal cancer.
    van Westreenen HL; Cobben DC; Jager PL; van Dullemen HM; Wesseling J; Elsinga PH; Plukker JT
    J Nucl Med; 2005 Mar; 46(3):400-4. PubMed ID: 15750150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Is 3'-deoxy-3'- [18F] fluorothymidine ([18F]-FLT) the next tracer for routine clinical PET after R [18F]-FDG?].
    Couturier O; Leost F; Campone M; Carlier T; Chatal JF; Hustinx R
    Bull Cancer; 2005 Sep; 92(9):789-98. PubMed ID: 16203269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression.
    Bashir A; Vestergaard MB; Marner L; Larsen VA; Ziebell M; Fugleholm K; Law I
    Brain; 2020 Dec; 143(11):3308-3317. PubMed ID: 33141151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing radioactive tracers 18F-FDG and 18F-FLT in the staging of diffuse large B-cell lymphoma by PET/CT examination: A single-center prospective study.
    Rybka J; Małkowski B; Olejniczak M; Chmielowska E; Sokołowska E; Kuliczkowski K; Wróbel T
    Adv Clin Exp Med; 2019 Aug; 28(8):1095-1099. PubMed ID: 31237123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
    Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
    Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
    Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
    J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.